205 related articles for article (PubMed ID: 23144978)
1. Bio-imaging of colorectal cancer models using near infrared labeled epidermal growth factor.
Cohen G; Lecht S; Arien-Zakay H; Ettinger K; Amsalem O; Oron-Herman M; Yavin E; Prus D; Benita S; Nissan A; Lazarovici P
PLoS One; 2012; 7(11):e48803. PubMed ID: 23144978
[TBL] [Abstract][Full Text] [Related]
2. Near infrared optical visualization of epidermal growth factor receptors levels in COLO205 colorectal cell line, orthotopic tumor in mice and human biopsies.
Cohen G; Lecht S; Oron-Herman M; Momic T; Nissan A; Lazarovici P
Int J Mol Sci; 2013 Jul; 14(7):14669-88. PubMed ID: 23857061
[TBL] [Abstract][Full Text] [Related]
3. Forkhead Box q1 promotes invasion and metastasis in colorectal cancer by activating the epidermal growth factor receptor pathway.
Zhang JJ; Cao CX; Wan LL; Zhang W; Liu ZJ; Wang JL; Guo Q; Tang H
World J Gastroenterol; 2022 May; 28(17):1781-1797. PubMed ID: 35633908
[TBL] [Abstract][Full Text] [Related]
4. In vivo fluorescence imaging for cancer diagnosis using receptor-targeted epidermal growth factor-based nanoprobe.
Ryu JH; Shin M; Kim SA; Lee S; Kim H; Koo H; Kim BS; Song HK; Kim SH; Choi K; Kwon IC; Jeon H; Kim K
Biomaterials; 2013 Dec; 34(36):9149-59. PubMed ID: 23998858
[TBL] [Abstract][Full Text] [Related]
5. Zwitterionic near-infrared fluorophore-conjugated epidermal growth factor for fast, real-time, and target-cell-specific cancer imaging.
Kim H; Cho MH; Choi HS; Lee BI; Choi Y
Theranostics; 2019; 9(4):1085-1095. PubMed ID: 30867817
[TBL] [Abstract][Full Text] [Related]
6. Molecular imaging of therapeutic response to epidermal growth factor receptor blockade in colorectal cancer.
Manning HC; Merchant NB; Foutch AC; Virostko JM; Wyatt SK; Shah C; McKinley ET; Xie J; Mutic NJ; Washington MK; LaFleur B; Tantawy MN; Peterson TE; Ansari MS; Baldwin RM; Rothenberg ML; Bornhop DJ; Gore JC; Coffey RJ
Clin Cancer Res; 2008 Nov; 14(22):7413-22. PubMed ID: 19010858
[TBL] [Abstract][Full Text] [Related]
7. Targeted elastin-like polypeptide fusion protein for near-infrared imaging of human and canine urothelial carcinoma.
Aayush A; Darji S; Dhawan D; Enstrom A; Broman MM; Idrees MT; Kaimakliotis H; Ratliff T; Knapp D; Thompson D
Oncotarget; 2022; 13():1004-1016. PubMed ID: 36082359
[TBL] [Abstract][Full Text] [Related]
8. Forkhead box K2 promotes human colorectal cancer metastasis by upregulating ZEB1 and EGFR.
Du F; Qiao C; Li X; Chen Z; Liu H; Wu S; Hu S; Qiu Z; Qian M; Tian D; Wu K; Fan D; Nie Y; Xia L
Theranostics; 2019; 9(13):3879-3902. PubMed ID: 31281520
[No Abstract] [Full Text] [Related]
9. Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes.
Pentheroudakis G; Kotoula V; De Roock W; Kouvatseas G; Papakostas P; Makatsoris T; Papamichael D; Xanthakis I; Sgouros J; Televantou D; Kafiri G; Tsamandas AC; Razis E; Galani E; Bafaloukos D; Efstratiou I; Bompolaki I; Pectasides D; Pavlidis N; Tejpar S; Fountzilas G
BMC Cancer; 2013 Feb; 13():49. PubMed ID: 23374602
[TBL] [Abstract][Full Text] [Related]
10. In vivo imaging of xenograft tumors using an epidermal growth factor receptor-specific affibody molecule labeled with a near-infrared fluorophore.
Gong H; Kovar J; Little G; Chen H; Olive DM
Neoplasia; 2010 Feb; 12(2):139-49. PubMed ID: 20126472
[TBL] [Abstract][Full Text] [Related]
11. Anti-Metastatic Activity of an Anti-EGFR Monoclonal Antibody against Metastatic Colorectal Cancer with
Ohishi T; Kato Y; Kaneko MK; Ohba SI; Inoue H; Harakawa A; Kawada M
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32839411
[TBL] [Abstract][Full Text] [Related]
12. Near infrared imaging of EGFR of oral squamous cell carcinoma in mice administered arsenic trioxide.
Zhang L; Wang K; Zhao F; Hu W; Chen J; Lanza GM; Shen B; Zhang B
PLoS One; 2012; 7(9):e46255. PubMed ID: 23029451
[TBL] [Abstract][Full Text] [Related]
13. Imaging epidermal growth factor receptor expression in vivo: pharmacokinetic and biodistribution characterization of a bioconjugated quantum dot nanoprobe.
Diagaradjane P; Orenstein-Cardona JM; Colón-Casasnovas NE; Deorukhkar A; Shentu S; Kuno N; Schwartz DL; Gelovani JG; Krishnan S
Clin Cancer Res; 2008 Feb; 14(3):731-41. PubMed ID: 18245533
[TBL] [Abstract][Full Text] [Related]
14. Regorafenib suppresses epidermal growth factor receptor signaling-modulated progression of colorectal cancer.
Liu YC; Tsai JJ; Weng YS; Hsu FT
Biomed Pharmacother; 2020 Aug; 128():110319. PubMed ID: 32502841
[TBL] [Abstract][Full Text] [Related]
15. Human α-defensin 6 (HD6) suppresses CRC proliferation and metastasis through abolished EGF/EGFR signaling pathway.
Wei PL; Lin JC; Hung CS; Makondi PT; Batzorig U; Chang TC; Huang CY; Chang YJ
Int J Med Sci; 2022; 19(1):34-46. PubMed ID: 34975297
[TBL] [Abstract][Full Text] [Related]
16. A comparative study of affibody, panitumumab, and EGF for near-infrared fluorescence imaging of EGFR- and EGFRvIII-expressing tumors.
Gong H; Kovar JL; Cheung L; Rosenthal EL; Olive DM
Cancer Biol Ther; 2014 Feb; 15(2):185-93. PubMed ID: 24100437
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of epidermal growth factor receptor family receptors and ligands in a mutant K-ras group of patients with colorectal cancer.
Nagaoka T; Kitaura K; Miyata Y; Kumagai K; Kaneda G; Kanazawa H; Suzuki S; Hamada Y; Suzuki R
Mol Med Rep; 2016 Apr; 13(4):3514-20. PubMed ID: 26935861
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor receptor-targeted molecular imaging of colorectal tumors: Detection and treatment evaluation of tumors in animal models.
Miyamoto Y; Muguruma N; Fujimoto S; Okada Y; Kida Y; Nakamura F; Tanaka K; Nakagawa T; Kitamura S; Okamoto K; Miyamoto H; Sato Y; Takayama T
Cancer Sci; 2019 Jun; 110(6):1921-1930. PubMed ID: 30973663
[TBL] [Abstract][Full Text] [Related]
19. In vivo breast cancer characterization imaging using two monoclonal antibodies activatably labeled with near infrared fluorophores.
Sano K; Mitsunaga M; Nakajima T; Choyke PL; Kobayashi H
Breast Cancer Res; 2012; 14(2):R61. PubMed ID: 22510481
[TBL] [Abstract][Full Text] [Related]
20. Dasatinib sensitizes KRAS mutant colorectal tumors to cetuximab.
Dunn EF; Iida M; Myers RA; Campbell DA; Hintz KA; Armstrong EA; Li C; Wheeler DL
Oncogene; 2011 Feb; 30(5):561-74. PubMed ID: 20956938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
